 |
|
|
||||||
|
|
|
 |
|
 |
|
 |
|
 |
|
|
|
|
|
|
|
|
INVESTOR INFORMATION | |||||
|
||||||
|
COMMON STOCK Quest Diagnostics Incorporated (ticker symbol: "DGX") shares are listed on the New York Stock Exchange. Options on Quest Diagnostics shares are traded on the Chicago Board Options Exchange.  The annual meeting of shareholders will be held on Tuesday, May 10, 2005, at The Waldorf-Astoria, New York, New York, at 10:30 A.M. Eastern Daylight Time. A proxy statement and annual report were mailed to shareholders of record as of March 14, 2005. ADDITIONAL INFORMATION Corporate news releases, our Annual Report, Proxy Statement, Forms 10-K and 10-Q and other information about the company, including locations of facilities, are available at Quest Diagnostics' website at: www.questdiagnostics.com Address all inquiries to: Investor Relations Department Quest Diagnostics Incorporated 1290 Wall Street West Lyndhurst, New Jersey 07071 (201) 393-5030 E-mail: investor@ questdiagnostics.com TRANSFER AGENT AND REGISTRAR National City Bank acts as transfer agent and registrar and dividend |
paying agent, and maintains all shareholder records for the company. If you have questions about the shares of Quest Diagnostics you own; wish to report a change of address or lost stock certificates or dividend checks; or would like to enroll in the company’s automatic dividend reinvestment or direct deposit program, please contact National City Bank directly: National City Bank Shareholder Services P.O. Box 92301 Cleveland, Ohio 44193-0900 Phone: (800) 622-6757 E-mail: shareholder.inquiries@ nationalcity.com CORPORATE HEADQUARTERS 1290 Wall Street West Lyndhurst, New Jersey 07071 (201) 393-5000 CORPORATE GOVERNANCE Corporate Governance Guidelines, the Code of Business Ethics and the charters of the committees of the Board are available at the Quest Diagnostics website. Any amendment to our Code of Business Ethics, as well as any waivers from certain provisions of the code relating to our CEO and senior financial officers, will be posted on our website. Quest Diagnostics has included as Exhibit 31 to its Annual Report on Form 10-K for fiscal year 2004 filed with the Securities and Exchange Commission certificates of Quest Diagnostics’ Chief Executive Officer and Chief Financial Officer regarding the quality of the company’s public |
disclosure. Quest Diagnostics has submitted to the New York Stock Exchange (NYSE) a certificate of its Chief Executive Officer certifying that he is not aware of any violations by Quest Diagnostics of the NYSE corporate governance listing standards. Inquiries to the Board of Directors may be sent via e-mail to: leadindependentdirector@ questdiagnostics.com TRADEMARKS Quest Diagnostics, Quest, the Sun-Q logo, ChartMaxx, and Nichols Institute are registered trademarks of Quest Diagnostics. Care360 and CardioCRP are trademarks of Quest Diagnostics. InSure is a trademark of Enterix Inc. CellSearch is a trademark of Veridex, LLC. Neither this report nor any statement contained herein is furnished in connection with any offering of securities or for the purpose of promoting or influencing the sale of securities. ©2005 Quest Diagnostics Incorporated. All rights reserved. Design: INC DESIGN, incdesign.com Black and white photography on Growth page was taken by James Anness/The Record. |
||||
|
||||||